Annual report pursuant to Section 13 and 15(d)

Note 17 - Stock-based Compensation and Other Benefit Plans - Weighted Average Assumptions (Details)

v3.23.1
Note 17 - Stock-based Compensation and Other Benefit Plans - Weighted Average Assumptions (Details) - $ / shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Weighted average exercise price - ($/share) (in dollars per share) $ 6.41 $ 3.14 $ 1.23
Expected life in years (Year) 6 years 6 years 6 years
Average expected volatility 72.00% 75.00% 74.00%
Risk-free interest rate 1.98% 0.95% 0.42%
Expected dividend yield 2.30% 0.00% 0.00%
Weighted average grant date fair value - ($/share) (in dollars per share) $ 2.84 $ 2.07 $ 0.79